There are FDA approved indications for these medications for obesity, but its a little bit like the wild, wild west as to which drug is going to be covered by which insurer for a particular patient, Lee said
The blockbuster new weight loss drugs, Wegovy and Ozempic, could become even more popular now that researchers have found that injections of semaglutide the drug in Wegovy and Ozempic sharply cut heart attacks, strokes and cardiac deaths in addition to helping people lose a significant percentage of weight
Coverage unavailable when GLP-1 coverable under Part D benefit Beneficiaries who are prescribed Wegovy or Zepbound for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the drug is on the Part D plans formulary (e.g., Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, or Wegovy to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease who are either obese or overweight), will not qualify for coverage of that drug under the Bridge Program
Related Articles Drug Formulary Tiers Explained: Step Therapy vs
